First Malaria Vaccine In Phase Three Clinical Trial
Mosqurix vaccine against malaria Malaria is an endemic disease cause by five species of plasmodium. The most prevalent of all the species is P. Falciparum. It is found in tropical environment like in Africa. More than 214 million case was recorded in the year 2015. The infection rate drop down in subsequent years only to witness a little rise of recnt. This shows that the present preventive and treatment plans are failing. Some of the preventive measures include the use of mosquito repellent treated bed net, windows and door screen and treating with antimalarial like artemisinin based combination therapy. This means the world especially Africa have to look for a good, cheap and effective alternative fast. This is where malaria vaccine comes into the picture. Read Also: How To Prevent Malaria There are several vaccines that have been attempted. Majority of them have failed to pass the first and second clinical phase. More are still under investigation. However, the first ap...
